Latest

AAN

·February 23, 2021·2 min read

Loss of Sense of Smell and Taste May Last up to 5 Months After COVID-19

51% of COVID-19 patients report they experienced the loss of smell and taste up to five months after infection. On average, once their senses were restored, people reported a loss in sensitivity to smell and taste.

Featured Neurology Neuroscience

·February 17, 2021·3 min read

White Matter Changes in Brain Found in Frontotemporal Dementia

Study reveals those with frontotemporal dementia have greater white matter hyperintensity than those with other forms of dementia. The amount of white matter hyperintensity was associated with the severity of FTD symptoms.

This shows a pregnant woman rubbing her belly

Featured Neurology

·February 3, 2021·3 min read

Moms With MS at No More Risk of Pregnancy Complications Than Moms Without MS

Contrary to popular belief, women with multiple sclerosis may not be at higher risk for complications during pregnancy, such as gestational diabetes or still-birth. However, babies of mothers with MS are more likely to be induced or believed by elective C-sections.

Featured Neurology Neuroscience

·January 27, 2021·3 min read

Can Large Fluid-Filled Spaces in the Brain Help Identify Those at Risk of Dementia?

Enlarged perivascular spaces around small blood vessels in the brain may be a biomarker for cognitive decline, and ultimately dementia, a new study reports.

This shows a man, question marks and a skeleton with its brain showing

Featured Neurology Neuroscience

·January 14, 2021·4 min read

Memory May Be Preserved in Condition With Brain Changes Similar to Alzheimer’s Disease

While 40% of people with primary progressive aphasia have underlying Alzheimer's disease, a new study suggests they may not develop the memory problems associated with Alzheimer's.

Featured Genetics Neurology Open Neuroscience Articles

·October 1, 2020·4 min read

Even in People With Parkinson’s Gene, Coffee May Be Protective

For carriers of the Parkinson's related LRRK2 gene, coffee consumption can help lower the risk of developing symptoms of the disease.

Featured Neurology Neuroscience

·September 27, 2020·5 min read

Multiple Unapproved Drugs Found in “Brain Boosting” Supplements

Researchers identified five unapproved drugs in dangerous combinations and doses in over-the-counter cognitive enhancement drugs. Side effects of the unapproved drugs include increases and decreases in blood pressure, agitation, and sedation.

Featured Genetics Neurology Neuroscience

·September 16, 2020·3 min read

Beyond Plaques and Tangles: Genetic Variation May Increase Risk of Cognitive Decline

A genetic variation that alters the metabolism of glutathione may be responsible for cognitive decline in people who do not have other associated biomarkers, a new study reports.

Featured Neurology

·September 2, 2020·6 min read

Common Drugs Tied to Increased Risk of Cognitive Decline

Anticholinergic medications, commonly used for conditions including allergies, high blood pressure, Parkinson's disease, and motion sickness, have been linked to an increased risk of cognitive decline and memory problems, especially in those with genetic risk factors for Alzheimer's disease.

Featured Neurology

·August 19, 2020·5 min read

Can a Healthy Diet Reduce Risk of Parkinson’s?

Eating a diet rich in vegetables and nuts during middle age is linked to fewer symptoms that may precede Parkinson's disease.

Featured Neurology

·August 19, 2020·3 min read

Is Risk of Alzheimer’s Linked to Specific Sleep Patterns?

Sleep disturbances may be an outcome of Alzheimer's in those with a genetic predisposition, but not a cause of dementia. Those with genetic risk factors for Alzheimer's tend to have shorter sleep durations and are more likely to be early risers but are less likely to suffer from insomnia.